Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06117306 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06117306 · ClinicalTrials.gov record · last posted 2026-08-26

MDMA-assisted Massed Prolonged Exposure for PTSD

Name: MDMA-assisted Massed Prolonged Exposure for PTSD — clinical trial record (NCT06117306)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MDMA-PE

StatusActive, Not Recruiting

PhasePhase 3

SponsorHealing Breakthrough

Started2024-10-25

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The overall objective of this study is to pilot the VASDHS-adapted Emory MDMA-PE Protocol (aE-MDMA-PE) and assess the effect on clinician-rated PTSD symptoms in veterans who receive different doses of MDMA.

Protocol amendment history 3 changes detected by DataLookout

2026-08-27

Enrollment closed, study ongoing

2026-08-27

Primary completion moved earlier: 2027-08-31 → 2027-03

2026-08-27

Completion moved earlier: 2027-08-31 → 2027-03

Trial Details

NCT Number	NCT06117306
Lead Sponsor	Healing Breakthrough Collaborators: San Diego Veterans Healthcare System, National Center for PTSD, White River Junction VA Medical Center, Resilient Pharmaceuticals
Conditions	Post-Traumatic Stress Disorder
Enrollment	20 participants
Start Date	2024-10-25
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-26